Speaker Profile
M.D., Ph.D., Assistant Professor of Medicine, Brigham & Women's Hospital
Biography
Dr. Kevin Wei is an Assistant Professor of Medicine at Harvard Medical School and an associate rheumatologist at Brigham and Women’s Hospital. Dr. Wei received his Bachelor of Science in biology from Duke University and his medical as well as doctoral degrees from Stanford University School of Medicine. He completed his internal medicine residency followed by a rheumatology fellowship at Brigham and Women’s Hospital. He is a member of the NIH’s Accelerating Medicines Partnership (AMP-RA/SLE) consortium. Dr. Wei is co-Director of the BWH Center for Cellular Profiling and Associate Director of the Harvard Medical School/BWH Joint Biology Consortium Cellular Systems Core. Dr. Wei’s research focuses on identifying novel cellular and molecular therapeutic targets in inflammatory diseases using single-cell and spatial technologies.
Talk
Towards Precision Medicine in Chronic Inflammatory Diseases.
n/a
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Priti Hegde, Kite Pharma
PMWC Award Ceremony
• Arie S. Belldegrun, Allogene Therapeutics
Keynote: The Industrialization of Cell Therapy:From Autologous Pioneers to Allogeneic Frontiers
• Arie S. Belldegrun, Allogene Therapeutics
Next Generation CAR-T Cell Therapies: Expanding Targets and Enhancing Designs
• Chair: Erin Harris Cell & Gene
• David Barrett, Kite Pharma
• Carl June, University of Pennsylvania
• Michel Sadelain, Columbia University
PMWC Award Ceremony
• Michel Sadelain, Columbia University
Keynote: Engineering the Future: Innovations in CAR-T Therapy Design
• Michel Sadelain, Columbia University
Tumor-Infiltrating Lymphocytes (TILs): Advances and Challenges in Solid Tumors
• Chair: Allison Betof Warner, Stanford University
• George Coukos, Ludwig Institute for Cancer Research
• Max Julve, Stanford
• Stephanie Goff, NIH/NCI
Allogeneic & In Vivo Cell Therapies: Manufacturing & Clinical Progress
• Chair: Arie S. Belldegrun, Allogene Therapeutics
• Zach Roberts, Allogene Therapeutics
• Adrian Bot, Capstan Therapeutics
• Priti Hegde, Kite Pharma
Smart Scaling: Leverating AI & Automation to De-Risk Advanced Therapy Manufacturing
• Chair: Stacie Calad-Thomson
• Samuel Rodriques, FutureHouse
• Manuel Leonetti, Biohub
• Fabian Gerlinghaus, Cellares
Designing Automated Platforms for Scalable Cell Therapy Manufacturing
• Fabian Gerlinghaus, Cellares
In Vivo CAR Therapy: Immune Reprogramming Directly in Patients
• Daniel Getts, Myloid Therapeutics
Operationalizing Cell & Gene Therapy Trials in a Large Health System
•Snehit Prabhu, Stanford
Gene Editing & Synthetic Biology for Therapy
• Chair: Trevor Martin, Mammoth Biosciences
• Ken Drazan, ArsenalBio
• Lynn Seely, Lyell
• Kole T. Roybal, Parker Institute
• David Kirn, 4DMT
